Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G et al (2017) SCENIC: single-cell regulatory network inference and clustering. Nat Methods 14:1083–1086

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali HR, Chlon L, Pharoah PDP, Markowetz F, Caldas C (2016) Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study. PLoS Med 13:e1002194

Article  PubMed  PubMed Central  Google Scholar 

Al-Salama ZT, Syed YY, Scott LJ (2019) Lenvatinib: a review in hepatocellular carcinoma. Drugs 79:665–674

Article  CAS  PubMed  Google Scholar 

Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O et al (2021) Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39:845-865.e7

Article  CAS  PubMed  Google Scholar 

Bagchi S, Yuan R, Engleman EG (2021) Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol 16:223–249

Article  CAS  PubMed  Google Scholar 

Butler A, Hoffman P, Smibert P, Papalexi E, Satija R (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36:411–420

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A et al (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25:1915–1927

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cappellini MD, Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet Lond Engl 371:64–74

Article  CAS  Google Scholar 

Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A (2020) Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 17:139–152

Article  PubMed  Google Scholar 

Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E et al (2017) From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 23:5282–5294

Article  PubMed  PubMed Central  Google Scholar 

Ding R, Sang S, Yi J, Xie H, Wang F, Dai A (2024) G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension. Aging 16:466–492

CAS  PubMed  PubMed Central  Google Scholar 

Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S et al (2022) Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin b 12:558–580

Article  CAS  PubMed  Google Scholar 

El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C et al (2017) Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet Lond Engl 389:2492–2502

Article  CAS  Google Scholar 

Ganesan P, Kulik LM (2023) Hepatocellular carcinoma: new developments. Clin Liver Dis 27:85–102

Article  PubMed  Google Scholar 

Gao J, Liang Y, Wang L (2022) Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol 13:888713

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A et al (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38:675–678

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR (2005) The pathophysiology of HOX genes and their role in cancer. J Pathol 205:154–171

Article  CAS  PubMed  Google Scholar 

Guruvaiah P, Chava S, Sun CW, Singh N, Penn CA, Gupta R (2023) ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE. PubMed [Internet]. [cited 2024 Nov 24]; Available from: https://pubmed.ncbi.nlm.nih.gov/37479754/

Herter FP, Weissman SG, Thompson HG, Hyman G, Martin DS (1961) Clinical experience with 6-aminonicotinamide. Cancer Res 21:31–37

CAS  PubMed  Google Scholar 

Hitosugi T, Zhou L, Elf S, Fan J, Kang H-B, Seo JH et al (2012) Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 22:585–600

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong W, Cai P, Xu C, Cao D, Yu W, Zhao Z et al (2018) Inhibition of glucose-6-phosphate dehydrogenase reverses cisplatin resistance in lung cancer cells via the redox system. Front Pharmacol 9:43

Article  PubMed  PubMed Central  Google Scholar 

Huang X, Wang L, Liu W, Li F (2019) MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2. Oncol Lett 17:3425–3431

CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Ou R, Chen X, Zhang Y, Li J, Liang Y et al (2021) Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC. J Exp Clin Cancer Res CR 40:304

Article  CAS  PubMed  Google Scholar 

Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S et al (2016) Genomic and transcriptomic features of Response to anti-PD-1 Therapy in metastatic Melanoma. Cell 165:35–44

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeong H, Lee S-Y, Seo H, Kim B-J (2021) Recombinant mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model. J Immunother Cancer 9:e003180

Article  PubMed  PubMed Central  Google Scholar 

Jiang P, Du W, Wu M (2014) Regulation of the pentose phosphate pathway in cancer. Protein Cell 5:592–602

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H et al (2021) Inference and analysis of cell-cell communication using Cell Chat. Nat Commun 12:1088

Article  CAS  PubMed  PubMed Central  Google Scholar 

Junttila MR, de Sauvage FJ (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501:346–354

Article  CAS  PubMed  Google Scholar 

Lee Y-K, Lim JJ, Jeoun U-W, Min S, Lee E-B, Kwon SM et al (2017) Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness. J Biol Chem 292:20208–20217

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Li C-W, Li X, Ding Q, Guo L, Liu S et al (2019) MET Inhibitors promote liver tumor evasion of the immune response by stabilizing PDL1. Gastroenterology 156:1849-1861.e13

Article  CAS  PubMed  Google Scholar 

Li J, Chen H, Bai L, Tang H (2024) Identification of CD8+ T-cell exhaustion signatures for prognosis in HBV-related hepatocellular carcinoma patients by integrated analysis of single-cell and bulk RNA-sequencing. BMC Cancer 24:53

Article  PubMed  PubMed Central